UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis

NCT06933563 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Myasthenia Gravis

Interventions

BIOLOGICAL: UCAR T-cell group

Sponsor

Zhejiang University

Collaborators

[object Object]